Stay updated with breaking news from Lynne Schofield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of haemolytic anaemia due to sickle cell disease (SCD) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
EAMS scientific opinion issued to argenx BV for efgartigimod alpha to treat adults with generalised Myasthenia Gravis (gMG), an autoimmune disease that causes muscle weakness. gMG can affect multiple muscle groups throughout the body.
Change doesn’t have to be expensive. It’s often sparked by a simple suggestion and a leader willing to give it a try.
EAMS scientific opinion issued to AbbVie Ltd for risankizumab in the treatment of moderately to severely active Crohn's disease.
EAMS scientific opinion issued to Advance Accelerator Applications for Lutetium (177Lu) vipivotide tetraxetanin in the treatment of adults with a certain type of advanced prostate cancer that has spread to other parts of the body and that has already been treated with other anticancer treatments.